Ymmunobio to Present at the Annual Meeting of the Association for Cancer Immunotherapy (CIMT)Apr 26, 2023
Mar 8, 2023Ymmunobio Accepted into Innosuisse Core CoachingParticipation in the international program guides startups in creating and developing business traction RIEHEN, SWITZERLAND, March 8,...
Mar 2, 2023Ymmunobio Welcomes Dr. Kanda and Dr. Khairnar to Advisory BoardMitsuro Kanda, MD, PhD, and Vishal Khairnar, PhD, join growing biotech company developing antibodies as therapies against various cancers...